VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
COO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
COOThe Cooper Companies, Inc.
$62.36$12.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCOOFinancials

The Cooper Companies, Inc. (COO) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has decelerated significantly to 0.6% in 2026Q3 from a high of 9.8% in 2024Q4, while gross margins have exhibited high volatility, swinging from 56.4% in 2025Q4 to 68.0% in 2026Q2.

Income StatementBalance SheetCash FlowRatios

COO Income Statement

Annual statement

COO Income Statement

The Cooper Companies, Inc. (COO) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMOct'25Oct'24Oct'23Oct'22Oct'21Oct'20Oct'19Oct'18Oct'17Oct'16Oct'15Oct'14Oct'13Oct'12Oct'11Oct'10Oct'09Oct'08Oct'07Oct'06Oct'05Oct'04Oct'03Oct'02Oct'01Oct'00Oct'99Oct'98Oct'97Oct'96
Sales/Revenue4.24B4.09B3.9B3.59B3.31B2.92B2.43B2.65B2.53B2.14B1.97B1.8B1.72B1.59B1.45B1.33B1.16B1.08B1.06B950.64M858.96M806.62M490.18M411.79M315.31M234.57M197.32M165.3M147.2M141.5M109.1M
Revenue Growth %4.73%5.06%8.41%8.61%13.2%20.22%-8.39%4.76%18.41%8.75%9.45%4.62%8.19%9.87%8.59%14.87%7.23%1.62%11.84%10.67%6.49%64.56%19.04%30.6%34.42%18.88%19.37%12.3%4.03%29.7%12.36%
Cost of Goods Sold1.54B1.61B1.3B1.24B1.17B966.7M896.1M896.6M900.5M773.2M793.7M726.8M626.21M560.92M521.13M526.03M481.79M483.93M437.35M431.11M332.98M309.79M174.35M146.59M115.81M81.2M68.1M59.01M50.9M24.7M17.6M
COGS % of Revenue-39.33%33.37%34.38%35.33%33.08%36.86%33.79%35.55%36.15%40.35%40.44%36.45%35.33%36.06%39.53%41.59%44.79%41.14%45.35%38.77%38.41%35.57%35.6%36.73%34.62%34.51%35.7%34.58%17.46%16.13%
Gross Profit2.7B2.48B2.6B2.36B2.14B1.96B1.53B1.76B1.63B1.37B1.17B1.07B1.09B1.03B924.01M804.8M676.72M596.49M610.03M519.53M525.98M496.83M315.83M265.2M199.49M153.37M133.12M109.15M96.3M64.1M48.5M
Gross Margin %63.64%60.67%66.64%65.62%64.67%66.92%63.14%66.21%64.45%63.85%59.64%59.56%63.55%64.67%63.94%60.47%58.41%55.21%57.38%54.65%61.23%61.59%64.43%64.4%63.27%65.38%67.46%66.03%65.42%45.3%44.45%
Gross Profit Growth %--4.35%10.09%10.2%9.4%27.43%-12.64%7.63%19.51%16.43%9.6%-1.95%6.31%11.13%14.81%18.93%13.45%-2.22%17.42%-1.23%5.87%57.31%19.09%32.94%30.07%15.21%21.96%13.34%50.23%32.16%20.95%
Operating Expenses2.15B1.8B1.89B1.82B1.63B1.45B1.22B1.23B1.2B936.7M849M833.6M785.08M685.72M635.61M577.25M486.39M442.75M481.55M464M406.69M352.54M199.08M169.96M132.53M98.61M86.25M70.33M66.5M44.2M34.2M
OpEx % of Revenue-43.98%48.52%50.78%49.33%49.62%50.31%46.31%47.57%43.79%43.17%46.39%45.7%43.19%43.98%43.37%41.98%40.98%45.29%48.81%47.35%43.71%40.61%41.27%42.03%42.04%43.71%42.55%45.18%31.24%31.35%
Selling, General & Admin1.89B1.63B1.53B1.5B1.34B1.21B992.5M996.6M973.3M799.1M722.8M712.54M683.12M596.65M559.9M513.14M433.06M391.59M429.3M407.95M357.84M297.95M190.53M162.85M126.73M89.77M75.42M61.7M56.2M38.3M29.7M
SG&A % of Revenue-39.78%39.37%41.78%40.57%41.44%40.83%37.56%38.43%37.36%36.75%39.65%39.77%37.58%38.74%38.56%37.38%36.24%40.38%42.91%41.66%36.94%38.87%39.55%40.19%38.27%38.22%37.33%38.18%27.07%27.22%
Research & Development169.8M172.2M155.1M137.4M110.3M92.7M93.3M86.7M84.8M69.2M65.4M69.6M66.26M58.83M51.73M43.58M35.27M33.3M35.47M39.86M34.55M42.88M6.49M5.57M4.32M3.66M2.71M1.98M1.9M1.7M1.2M
R&D % of Revenue-4.21%3.98%3.82%3.33%3.17%3.84%3.27%3.35%3.24%3.33%3.87%3.86%3.71%3.58%3.27%3.04%3.08%3.34%4.19%4.02%5.32%1.32%1.35%1.37%1.56%1.37%1.2%1.29%1.2%1.1%
Other Operating Expenses2M0201.2M186.2M179.5M146.1M137.2M145.8M146.7M68.4M60.8M51.5M35.71M30.24M23.98M20.53M18.06M17.86M16.77M16.19M14.3M11.7M2.05M1.53M1.48M5.18M4.21M3.8M8.4M4.2M3.3M
Operating Income544.6M682.9M705.7M533.1M507.6M505.8M311.8M546.7M403.1M429.1M324.1M236.7M306.49M305.94M283.4M227.56M189.91M149.86M126.96M45.85M112.9M135.83M116.75M95.24M66.97M54.76M46.87M38.81M29.8M19.9M14.3M
Operating Margin %12.85%16.69%18.12%14.84%15.34%17.31%12.83%20.6%15.92%20.06%16.48%13.17%17.84%19.27%19.61%17.1%16.39%13.87%11.94%4.82%13.14%16.84%23.82%23.13%21.24%23.34%23.75%23.48%20.24%14.06%13.11%
Operating Income Growth %--3.23%32.38%5.02%0.36%62.22%-42.97%35.62%-6.06%32.4%36.92%-22.77%0.18%7.96%24.54%19.82%26.73%18.03%176.89%-59.39%-16.88%16.35%22.58%42.21%22.3%16.83%20.76%30.24%49.75%39.16%76.54%
EBITDA928.6M1.11B1.08B900.8M853.7M815.1M631.4M827.5M678.2M617.5M522.4M428.1M444.69M431.29M394.61M325.7M283.91M242.46M209.15M130.37M174.55M184.47M132.4M107.77M78.34M65.75M55.6M47.25M38.2M24.1M17.6M
EBITDA Margin %21.92%27.02%27.75%25.07%25.8%27.89%25.97%31.19%26.78%28.87%26.56%23.82%25.89%27.16%27.31%24.47%24.51%22.44%19.67%13.71%20.32%22.87%27.01%26.17%24.85%28.03%28.18%28.59%25.95%17.03%16.13%
EBITDA Growth %-16.41%2.32%19.98%5.52%4.74%29.09%-23.7%22.01%9.83%18.2%22.03%-3.73%3.11%9.3%21.16%14.72%17.1%15.93%60.43%-25.31%-5.38%39.33%22.86%37.56%19.16%18.24%17.68%23.69%58.51%36.93%54.39%
D&A (Non-Cash Add-back)384M423M375.1M367.7M346.1M309.3M319.6M280.8M275.1M188.4M198.3M191.4M138.2M125.35M111.21M98.15M94M92.6M82.19M84.51M61.65M48.64M15.65M12.53M11.37M10.99M8.73M8.44M8.4M4.2M3.3M
EBIT526.3M630.4M696.6M518.2M532.6M514.6M303.3M545.4M414.6M427.4M321.8M233.6M304.5M321.44M287.22M210.11M161.09M158.97M126.99M55.53M119.28M144.3M116.75M95.24M66.97M54.76M46.87M38.81M29.8M19.9M14.3M
Net Interest Income-94.6M-100M-114.3M-105.3M-57.3M-23.1M-36.8M-68M-82.7M-33.4M-26.2M-18.1M-7.96M-9.17M-11.77M-17.34M-36.67M-44.14M-50.78M000000000000
Interest Income0000000000000000000000000000000
Interest Expense94.6M100M114.3M105.3M57.3M23.1M36.8M68M82.7M33.4M26.19M18.1M7.96M9.17M11.77M17.34M36.67M44.14M53.77M67.5M58.65M43.55M2.52M2.55M01.52M5.17M2.8M25.1M20.9M4.1M
Other Income/Expense-82.2M-116.4M-123.4M-120.2M-32.3M-14.3M-45.3M-91.4M-71.2M-35.1M-28.5M-21.2M-9.95M6.33M-7.95M-34.79M-65.49M-35.03M-50.76M-45.18M-39.56M-27.38M-4.26M-4.75M-1.8M-2.63M-4.74M-6.1M-6.7M-2.9M-3.1M
Pretax Income462.4M566.5M582.3M412.9M475.3M491.5M266.5M477.4M331.9M394M295.63M215.49M296.53M312.27M275.45M192.76M124.43M114.83M76.21M672K73.34M108.46M112.49M90.49M65.17M52.13M42.13M32.7M23.1M21.8M12.1M
Pretax Margin %10.91%13.84%14.95%11.49%14.37%16.82%10.96%17.99%13.1%18.42%15.03%11.99%17.26%19.67%19.06%14.48%10.74%10.63%7.17%0.07%8.54%13.45%22.95%21.97%20.67%22.22%21.35%19.78%15.69%15.41%11.09%
Income Tax-107.9M191.6M190M118.7M89.5M-2.45B28.1M10.7M192M21.1M20.7M10.34M24.7M15.37M26.81M17.33M11.62M14.28M10.73M11.86M7.1M16.73M19.66M21.72M16.29M14.99M12.73M10.7M-34.7M-26.6M-4.5M
Effective Tax Rate %-23.33%33.82%32.63%28.75%18.83%-499.13%10.54%2.24%57.85%5.36%7%4.8%8.33%4.92%9.73%8.99%9.34%12.44%14.08%1765.48%9.69%15.43%17.48%24%25%28.76%30.21%32.72%-150.22%-122.02%-37.19%
Net Income570.3M374.9M392.3M294.2M385.8M2.94B238.4M466.7M139.9M372.9M273.92M203.52M269.86M296.15M248.34M175.43M112.8M100.55M65.48M-11.19M66.23M91.72M92.83M68.77M48.88M37.14M28.97M25.1M39.8M31.4M16.6M
Net Margin %13.46%9.16%10.07%8.19%11.66%100.76%9.81%17.59%5.52%17.43%13.93%11.33%15.71%18.65%17.18%13.18%9.74%9.31%6.16%-1.18%7.71%11.37%18.94%16.7%15.5%15.83%14.68%15.18%27.04%22.19%15.22%
Net Income Growth %39.85%-4.44%33.34%-23.74%-86.9%1135.19%-48.92%233.6%-62.48%36.14%34.59%-24.58%-8.88%19.25%41.56%55.52%12.19%53.56%685.02%-116.9%-27.79%-1.19%34.98%40.71%31.61%28.2%15.41%-36.93%26.75%89.16%16500%
Net Income (Continuing)570.3M374.9M392.3M294.2M385.8M2.94B238.4M466.7M139.9M372.9M274.9M205.14M271.83M296.91M248.64M175.43M112.8M100.55M65.48M-11.19M66.23M91.72M92.83M68.77M48.88M37.14M29.4M22M57.8M43.7M15.6M
Discontinued Operations0000000000000000000000000000000
Minority Interest200K200K200K200K200K200K200K200K200K100K168K6.39M18.56M18.96M20.41M0000000000000000
EPS (Diluted)2.951.871.961.481.9414.794.819.322.817.525.594.145.515.965.053.632.432.211.43-0.251.442.042.592.091.571.221.000.881.311.200.71
EPS Growth %44.34%-4.59%32.43%-23.71%-86.88%207.48%-48.39%231.67%-62.63%34.53%35.02%-24.86%-7.55%18.02%39.12%49.38%9.95%54.55%672%-117.36%-29.41%-21.24%23.92%33.12%28.69%22%13.64%-32.82%9.17%69.01%-
EPS (Basic)-1.881.971.491.9614.934.869.472.857.635.654.205.616.095.183.742.482.231.46-0.251.492.062.832.201.601.251.020.891.351.200.72
Diluted Shares Outstanding193.4M200M200.4M199.2M198.8M199.4M198.2M200.2M198.8M198.4M196M196.8M195.84M198.74M196.61M193.24M186.02M181.91M187.38M178.83M190.28M179.85M143.36M132.98M124.76M121.97M116.08M114.5M122.15M103.43M94.18M
Basic Shares Outstanding193.4M200M198.9M198M197.2M197.2M196.4M197.2M196.4M195.6M194M194M192.24M194.46M191.65M187.62M182.12M180.69M179.98M178.83M178.09M165.03M129.87M124.9M122.23M118.7M113.5M112.78M118.62M103.43M92.87M
Dividend Payout Ratio---1.02%0.78%0.1%1.26%0.64%2.07%0.78%1.06%1.43%1.07%0.99%1.15%1.61%2.42%2.7%4.12%-4.03%2.51%2.09%2.84%3.12%2.8%3.91%2.39%---

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Volatile Margins & Earnings Quality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Growth Deceleration Amidst Macro Headwinds

COO's revenue growth trajectory has decelerated significantly, falling from a high of 9.8% in 2024Q4 to just 0.6% in the most recent quarter, suggesting the post-pandemic demand surge in vision care may be normalizing.

The decelerating trend from mid-single-digit growth toward near-flat results implies that volume drivers like myopia management penetration are maturing or facing near-term saturation. The resilience of the CooperVision segment is now being tested by what appears to be general market softness, shifting the investment thesis toward cost discipline and margin defense rather than top-line acceleration.

Gross Margin Volatility Masking Structural Strength

While the 10-quarter average gross margin is a robust 65.0%, the significant volatility—plunging to 56.4% in 2025Q4 before rebounding—indicates exposure to raw material costs, manufacturing inefficiencies, or unfavorable product mix shifts that warrant closer scrutiny.

The company's ability to sustain a premium gross margin above 60% suggests enduring pricing power in its specialty lens portfolio. However, the instability, particularly the Q4 trough, signals that the high fixed-cost manufacturing base is highly sensitive to utilization rates and input cost fluctuations, a risk not fully appreciated in a simple average.

SG&A Anomaly Signals Integration or Restructuring

The extraordinary SG&A spike to $676.2M in 2026Q2, which dwarfed the typical ~$400M quarterly run rate, drove an operating loss and appears to be a non-recurring event linked to acquisition integration or restructuring within CooperSurgical.

This isolated quarter demonstrates the operational risk inherent in COO's 'string-of-pearls' acquisition strategy, where integration charges can temporarily obliterate profitability. Excluding this event, the underlying SG&A discipline appears consistent, but investors should monitor whether such costs become recurring as the fertility portfolio expands.

Net Income Distorted by Non-Operating Items

The stark divergence between operating income and net income—with net margin swinging from -7.2% to 40.6% in consecutive quarters—indicates significant non-operating items, likely related to tax adjustments, acquisition accounting, or gains/losses on financial instruments.

This volatility obscures the true cash-generating power of the core operations and makes EPS a poor predictor of underlying performance. The zero reported stock-based compensation across all periods is highly unusual and likely indicates its inclusion within another line item, potentially masking its dilutive impact on shareholders.

2026Q2 Loss Marks a Painful Integration Event

The quarter ending May 2026 represents a critical inflection point where COO posted its only operating loss, driven by a massive SG&A surge that appears to be a one-time charge related to recent surgical segment acquisitions.

This event temporarily broke the company's consistent profitability trend but may have cleared the path for a cleaner cost structure, as evidenced by the swift return to strong operating margins in 2026Q3. The lasting impact will be determined by whether the expected synergies from this investment materialize without further operational disruption.

Profitability Relies on Cost Containment, Not Growth

The most pressing challenge to the investment case is that COO's margin expansion appears to be driven by cost control and mix shifts rather than sustainable revenue growth, as evidenced by flat topline results alongside improving operating income.

With revenue growth stalling near zero, the impressive 20.9% operating margin in 2026Q3 is vulnerable to any future SG&A inflation or R&D spending increases required to fend off competitors like Alcon. This strategy of optimizing profitability in a no-growth environment is inherently limited and raises questions about the durability of future earnings power.

COO — Frequently Asked Questions

Quick answers to the most common questions about buying COO stock.

What was The Cooper Companies, Inc.'s (COO) revenue in 2025?

For fiscal year 2025, The Cooper Companies, Inc. (COO) reported total revenue of $4.09B. This represents a 3651.1% increase compared to $109.1M in 1996.

Is The Cooper Companies, Inc. (COO) profitable?

The Cooper Companies, Inc. (COO) is profitable, generating $374.9M in net income for the fiscal year ending 2025 with a net profit margin of 9.2%.

What is The Cooper Companies, Inc.'s operating profit margin?

The Cooper Companies, Inc. (COO) reported an operating income of $682.9M, resulting in an operating profit margin of 16.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is The Cooper Companies, Inc.'s gross profit and gross margin?

The Cooper Companies, Inc. (COO) generated $2.48B in gross profit for the year, representing a gross profit margin of 60.7%. This demonstrates the company's core pricing power and production efficiency.